PENPenumbra, Inc.

$13B

Q4 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$121M+25.8% YoY

Gross Profit

$79M65.2% margin

Operating Income

$7M5.5% margin

Net Income

$7M5.5% margin

EPS (Diluted)

$0.18

QoQ Revenue Growth

+8.0%

Cash Flow

Operating Cash Flow

$8M

Free Cash Flow

$4M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$515M

Total Liabilities

$93M

Stockholders' Equity

$422M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$121M	$96M	+25.8%
Gross Profit	$79M	$64M	+23.5%
Operating Income	$7M	$4M	+73.0%
Net Income	$7M	$9M	-26.7%

PEN Q4 2018 Earnings — Penumbra, Inc. Revenue & Financial Results | Market Cap Arena